Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 8Completed 5Active not recruiting 5Withdrawn 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1Dermatologic 1

Conditions

Melanoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 5Nivolumab 3Biopsy 3Magnetic Resonance Spectroscopy 2Docetaxel 2tivozanib 1talazoparib 1romidepsin 1pembrolizumab 1olaparib 1imisopasem manganese 1gallium 68 PSMA-11 1durvalumab 1balstilimab 1atezolizumab 1aldesleukin 1abivertinib 1abiraterone 1abarelix 1Standard of Care 1Radiosurgery 1Practice Guidelines as Topic 1Palliative Care 1Paclitaxel 1Oxycodone 1N-acetylcochinol-O-phosphate 1Mental Status and Dementia Tests 1Menogaril 1Magnetic Resonance Imaging 1Ketorolac 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Practice Guidelines as Topic × Genitourinary × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡